Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-31

Clinical Trial Update: A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer [Phase 3]

View source ↗

Summary

This document reports a Phase 3 multi-center randomized trial evaluating intraportal chemotherapy combined with the mFOLFOX6 adjuvant regimen for Stage II-III c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mFOLFOX6 chemotherapy regimen (FOLFOX6 consisting of oxaliplatin, leucovorin, and 5-fluorouracil)

Snippet

Sponsor: Xu jianmin | Conditions: Colorectal Cancer, Metastasis | Phase 3 | Status: UNKNOWN